STOCK TITAN
  1. Home
  2. News
  3. PHR

Phreesia Inc - PHR STOCK NEWS

Welcome to our dedicated news page for Phreesia (Ticker: PHR), a resource for investors and traders seeking the latest updates and insights on Phreesia.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Phreesia's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Phreesia's position in the market.

News
Phreesia Achieves HITRUST Risk-Based, 2-Year Certification Demonstrating the Highest Level of Information Protection Assurance
Rhea-AI Summary
Phreesia (PHR) Achieves HITRUST Risk-based Certified Status for Patient Intake Platform and Data Centers, Demonstrating High Information Security Standards and Compliance
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.45%
Tags
none
-
News
Phreesia Sets Release Date for Fiscal Third Quarter 2024 Results
Rhea-AI Summary
Phreesia, Inc. (NYSE: PHR) will release its fiscal third quarter 2024 financial results on December 5, 2023. The results will be announced through a press release and quarterly stakeholder letter on the company's investor website. A conference call to discuss the results will be held at 5PM Eastern Time on the same day. A replay of the call will be available for on-demand listening.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.95%
Tags
earnings
-
News
Phreesia Announces Second Quarter Fiscal 2024 Results
Rhea-AI Summary
Phreesia Inc. reports Q2 2023 financial results. Total revenue increased by 26% to $85.8 million. Net loss decreased to $36.8 million. Cash and cash equivalents decreased to $127.7 million. Acquired MediFind for $9.0 million and Access eForms for $38.4 million. Maintaining revenue outlook for FY2024 at $353-356 million. Raising Adjusted EBITDA outlook to negative $54-49 million. Maintaining $500 million revenue target for FY2025. Expecting profitability in FY2025.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-22.11%
Tags
earnings
News
Phreesia Named to The Software Report’s “Top 100 Software Companies” for the Second Consecutive Year
Rhea-AI Summary
Phreesia has been selected as one of the 'Top 100 Software Companies of 2023' by The Software Report. The evaluation is based on factors like product functionality, innovative capabilities, ESG involvement, and long-term viability. This is the second consecutive year that Phreesia has made the list. Other awardees include Adobe, Groove, and Pantheon.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.38%
Tags
none
-
News
Phreesia Awards Inducement Grants as Part of its Acquisition of Access eForms
Rhea-AI Summary
Phreesia, Inc. has approved the grant of restricted stock unit awards to 24 new non-executive employees. The awards, totaling 12,285 shares of common stock, were made on August 15, 2023, in accordance with the 2023 Inducement Award Plan. The awards will vest annually over a four-year period, subject to continued employment.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.38%
Tags
acquisition
-
News
Phreesia Acquires Access, Expanding its Offerings for Acute-Care Hospitals and Continuing to Drive Efficiency and a Better Patient Experience
Rhea-AI Summary
Phreesia (PHR) has acquired Access eForms, an electronic forms management provider, to enhance its patient intake, outreach, and activation services for healthcare organizations. Access eForms brings expertise in delivering thousands of forms used in healthcare settings and has seamless integrations with leading EHRs, including MEDITECH. The acquisition aims to help hospitals streamline workflows, improve compliance, and deliver a better patient experience, in line with Phreesia's focus on making care more convenient and patient-centered.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.93%
Tags
acquisition
News
Phreesia Sets Release Date for Fiscal Second Quarter 2024 Results
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.54%
Tags
earnings
-
News
Phreesia Acquires MediFind, Reinforcing its Commitment to Patient-Centered Care and Expanding its Offerings to Consumers
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
acquisition
-
News
Phreesia Names Lisa Egbuonu-Davis to its Board of Directors
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.8%
Tags
management
News
Phreesia Announces First Quarter Fiscal 2024 Results
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.86%
Tags
earnings
Stock PHR logo
Phreesia Inc

NYSE:PHR

PHR Rankings

#2311 Ranked by Market Cap
#4785 Ranked by Stock Gains
N/A Ranked by Dividends

PHR Stock Data

1.33B
53.49M
4.78%
94.64%
3.84%
Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Professional, Scientific, and Technical Services
Link
United States
Raleigh

About PHR

leading healthcare organizations choose phreesia to revolutionize their point of service. in medical groups of all sizes, phreesia’s flexible and scalable platform drives tangible results across administrative, financial and clinical operations so that staff can focus on providing exceptional patient care.